From: Antibiotic prophylaxis at the time of dental implant placement: a cost-effectiveness analysis
Strategy | Cost (EUR) | Incremental Cost | Effectiveness (GOHAI) | Incremental E | ICER | NMB | |
---|---|---|---|---|---|---|---|
Societal perspective | |||||||
All referencing common baseline | |||||||
Antibiotics | 1037,61 | 0,879,495 | 1600,87 | undominated abs. Dominated | |||
No Antibiotics | 1042, 56 | 4,95 | 0,878,208 | −0,00129 | −3841,18 | 1592,06 | |
Patient’s perspective | |||||||
All referencing common baseline | |||||||
Antibiotics | 1023,64 | 0,879,495 | 1614,84 | undominated abs. Dominated | |||
No Antibiotics | 1042,56 | 18,92 | 0,878,208 | −0,00129 | −14,692,64 | 1592,06 |